Medical Design Excellence Awards is the Premier Award Program for
Medical Technology

COLUMBUS, Ohio, April 8, 2008 /PRNewswire-USNewswire/ -- MEDRAD, Inc.
and Battelle, the world's largest non-profit independent research and
development organization, today announced the winning of a Medical Design
Excellence Award (MDEA) for the MEDRAD XDS(TM) Extravasation Detector, a
technology that enhances the safety of contrast media injection through
early detection of extravasations. Extravasation is leakage of fluid,
including contrast media, drugs, or solutions, from a vein into the
surrounding tissue during intravenous administration.

The MDEA competition is a prestigious program recognizing medical
product excellence and the achievements of medical product manufacturers
(and the people who are responsible for groundbreaking innovations that are
changing the face of healthcare). An impartial, multi-disciplinary panel of
jurors with expertise in biomedical engineering, human factors, industrial
design, medicine, and diagnostics reviewed the entries and selected the
winners.

"We thank MD&DI for this prestigious MDEA that recognizes our XDS
Extravasation Detector technology, the investment of many resources for
research and development, and the inherent risk of developing medical
devices; the MDEA validates that the investment and risk were worth it,"
said Cliff Kress, senior vice president, MEDRAD CT Business Unit. "We're
also proud that we succeeded where others have not in developing an
extravasation technology with a major impact on safety and a minor impact
on workflow."

Battelle worked closely with MEDRAD to develop the technology from
exploration through product development. MEDRAD and Battelle jointly
invented the electrical permittivity technology that enables XDS(TM) and
developed the commercial product.

"Battelle is pleased that our long-standing relationship with MEDRAD
has yielded this breakthrough product," said Barbara Kunz, President,
Battelle Health and Life Sciences Global Business. "Together, we have made
a difference in patient safety and have improved the quality of care for
patients undergoing imaging studies."

MEDRAD and Battelle will accept the award at a ceremony on June 4,
2008, at the Medical Design & Manufacturing (MD&M) East 2008 Conference and
Exposition in New York City. Additionally, the MEDRAD XDS(TM) Extravasation
Detector will appear with the other MDEA winners in the April 7 issue of
Medical Device & Diagnostic Industry (MD&DI).

About Battelle

Battelle's Global Health and Life Sciences business delivers a
comprehensive set of R&D services to solve complex challenges for
government health agencies and medical device, biotechnology, and
pharmaceutical firms. Including its national laboratories, Battelle
oversees over $200 million annually in health and life sciences-research
contributing to advances in medical devices, pharmaceuticals, public
health, and next-generation diagnostics and therapeutics.

Battelle is the world's largest non-profit independent research and
development organization, overseeing 20,000 employees in more than 130
locations worldwide, including five national laboratories Battelle manages
or co-manages for the U.S. Department of Energy. Headquartered in Columbus,
Ohio, Battelle conducts $4 billion in R&D annually through contract
research, laboratory management, and technology commercialization. As a
non-profit charitable trust with an eye toward the future, Battelle
actively supports and promotes science and math education.

(Date:12/9/2016)... December 9, 2016 The research ... five players in the Global Label-Free Array Systems Market ... market in 2015. Players such as Biacore, Agilent Technologies, ... dominant in the global market due to their unmatched ... innovation. Product upgrades and timely product launches are expected ...

(Date:11/21/2016)... , Nov. 21, 2016 Neurotechnology ... object recognition technologies, today announced that the MegaMatcher ... cards was submitted for the NIST Minutiae ... passed all the mandatory steps of the evaluation ... is a continuing test of fingerprint templates used ...